MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-10-0009850
Aspiris Pharmaceuticals Private Limited
Aspiris Pharmaceuticals Private Limited - chemicals in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹14.4 Lakh
▲ 175% YoY
Net profit · FY 2024
₹9,890
Net margin 0.7%
EBITDA · FY 2024
₹16,471
EBITDA margin 1.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Aspiris Pharmaceuticals Private Limited
Data last updated:
Aspiris Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 14 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33119DL2012PTC246185. Its GSTIN is 09AALCA4302R1Z9 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Gagan Deep Jha and Vaibhav Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 4/100 – A Bengali Colony Mahavir Enclave, Delhi, India – 110045.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.4 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹9,890 (net margin 0.7%) and EBITDA of ₹16,471 (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 3% over five years.
Aspiris Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0009850). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U33119DL2012PTC246185
Registration Number 246185
Incorporation Date 14 December 2012
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0009850
Recognitions & Rankings of Aspiris Pharmaceuticals
Contact details
Aspiris Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 4/100 – A Bengali Colony Mahavir Enclave, Delhi, India – 110045
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Aspiris Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Aspiris Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aspiris Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aspiris Pharmaceuticals Private Limited, buy the company report.
Financials of Aspiris Pharmaceuticals Private Limited
FY 2025 filings availableAspiris Pharmaceuticals Private Limited reported revenue of ₹14.4 Lakh (up 175% YoY) for FY 2024.
Revenue · FY 2024
₹14.4 Lakh ▲ 175%
Net profit · FY 2024
₹9,890 margin 0.7%
EBITDA · FY 2024
₹16,471 margin 1.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 175%
3 years · compounded
▲ 16%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 91%
3 years · compounded
▲ 48%
5 years · compounded
▼ 8%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 175% growth in the latest year. EBITDA rose 91% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16,471 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9,890 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aspiris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aspiris Pharmaceuticals Private Limited
Aspiris Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gagan Deep Jha Also directs: Saga Vacations Private Limited | Director | 14 Dec 2012 | 13 Years 10 Months | Current |
| Vaibhav Gupta | Director | 10 Mar 2018 | 8 Years 7 Months | Current |
| Monika Gupta | Director | 14 Dec 2012 | 13 Years 10 Months | Current |
Auditor
Aspiris Pharmaceuticals Private Limited is audited by V.G.K. & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.G.K. & ASSOCIATES | FY 2017 | 007498C |
Shareholding
The shareholding of Aspiris Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Aspiris Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aspiris Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aspiris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aspiris Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AALCA4302R1Z9 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aspiris Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aspiris Pharmaceuticals Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Vaibhav Gupta ceased to be Additional Director on 25 Sep 2018.
AGM
Aspiris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aspiris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Vaibhav Gupta ceased to be Additional Director.
Appointed
Vaibhav Gupta was appointed as Director.
Appointed
Gagan Deep Jha was appointed as Director.
Appointed
Monika Gupta was appointed as Director.
Incorporation
14 Dec 2012
Aspiris Pharmaceuticals Private Limited was registered on 14 Dec 2012 with Roc Delhi & aged 13 years 10 months as per MCA records.
Frequently asked questions
Aspiris Pharmaceuticals is an active private limited company based in Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 14 December 2012 (14+ years old) and is registered under CIN U33119DL2012PTC246185.
Aspiris Pharmaceuticals has 3 current directors:
- Gagan Deep Jha - Director
- Vaibhav Gupta - Director
- Monika Gupta - Director
The latest financial statements of Aspiris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aspiris Pharmaceuticals is 09AALCA4302R1Z9, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Aspiris Pharmaceuticals is U33119DL2012PTC246185. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aspiris Pharmaceuticals was incorporated on 14 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Vaibhav Gupta ceased to be Additional Director on 25 Sep 2018. Vaibhav Gupta was appointed as Director on 10 Mar 2018. Gagan Deep Jha was appointed as Director on 14 Dec 2012. Aspiris Pharmaceuticals has 4 board changes on record in total.
Yes, Aspiris Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0009850).
The registered office of Aspiris Pharmaceuticals is at House No. 4100 – A Bengali Colony Mahavir Enclave, Delhi, India – 110045.
Aspiris Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages